#3TC

@angmonroe.bsky.social

1 month ago

Three Things Challenge #MM326 #TTC #3TC #threethingschallenge #jovial #jelly #jaundice url:www.angelascottauthor.com/this-was-supposed-to-be/...

0 0 0 0

Adam R Houston

@healthlawadamh.bsky.social

1 month ago

Screenshot of the following text with all language relating to BioChem highlighted: "For years, Canadian University presidents exhorted governments to invest more in research to power innovation and economic growth. In a 2017 opinion piece, the presidents of three universities highlighted the stories of the remarkable research of Geoffrey Hinton in artificial intelligence (AI), Bernard Belleau in developing a HIV/AIDS treatment and in creating BioChem Pharma, and Michael Smith on site-directed mutagenesis. While groundbreaking and contributing to Canadian research prowess, the innovations in all these cases left the country, contributing to foreign rather than Canadian economic growth. Dr. Hinton left for the U.S. and, when he returned, continued to provide Google with his patents. BioChem Pharma licensed its product to GlaxoSmithKline at the preclinical stage, leaving most of the development (and the economic benefits) to its foreign licensee. Further, Dr. Belleau and his colleagues sold BioChem Pharma to Shire Pharmaceuticals in 2000 for $13 billion, a windfall to its shareholders with little benefit to Canada. As for Dr. Smith, while he brought to Canada the prestige of the Nobel Prize in chemistry, he left the development of his research to the U.S. with the of what is now Zymo Research and patents held by collaborators at the California Institute of Technology."

Interesting article by @richardgold.bsky.social on university R&D and economic growth "Recalibrating Canadian universities to meet the Mark (Carney)"
universityaffairs.ca/opinion/reca...
Was also thinking this very week that #3TC / #Lamivudine was an example of this issue that should be used more...

2 1 0 0